Search - tctmd.com

Displaying 41 - 60 of 88

Sort: Relevancy | Date

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

Presentation TCT Abstracts Posters 2018

Comparison of midterm outcome between small and non-small vessel after paclitaxel coated balloon treatment in de novo native coronary artery disease

Presenter: Ritsu Yoshida

September 25, 2018

Presentation TCT 2018

DCB for Coronary Artery Disease: In-Stent Restenosis, NSTEMI, and Small Vessels

Presenter: Juan F. Granada, Bruno Scheller

September 23, 2018

News Conference News ESC 2018

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

Todd Neale

August 28, 2018

News Conference News EuroPCR 2018

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

Caitlin E. Cox

May 25, 2018

News Conference News ACC 2018

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

Caitlin E. Cox

March 14, 2018

News Industry News

Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels

February 26, 2018

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Leah Lawrence

August 10, 2017

News Industry News

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

May 18, 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS in China, Japan

News Conference News EuroPCR 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Michael O'Riordan

May 17, 2017

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

News Conference News ISET 2017

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

Caitlin E. Cox

February 17, 2017

News Daily News

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Yael L. Maxwell

December 23, 2016

News Conference News EuroPCR 2016

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Michael O'Riordan

May 17, 2016

News Daily News

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

Michael O'Riordan

March 30, 2016

News Daily News

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

Michael O'Riordan

March 16, 2016

News Daily News

FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting

Michael O'Riordan

March 14, 2016

News Industry News

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

February 01, 2016

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

Advertisement

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Comparison of midterm outcome between small and non-small vessel after paclitaxel coated balloon treatment in de novo native coronary artery disease

DCB for Coronary Artery Disease: In-Stent Restenosis, NSTEMI, and Small Vessels

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

Boston Scientific Announces Scheduled Presentations At TCT 2015

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content